Output

Meetings
During the year, the Child and Adolescent Neuropsychopharmacology Network organises meetings for its members (also at the annual ECNP Congress).

Research projects

  • conect4children (Collaborative Network for European Clinical Trials for Children)
    European Union’s Horizon 2020 research and innovation programme and EFPIA, Grant Agreement no. 777389.

  • PERS (Pediatric European Risperidone Studies)

  • STOP (Suicidality: Treatment Occurring in Paediatrics)

  • ADDUCE (Attention-Deficit Hyperactivity Disorder Drugs Use Chronic Effects)
    European Union’s Seventh Framework Programme for research, technological development and demonstration, Grant Agreement no. 603016.

  • TACTICS (Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes)
    European Community's Seventh Framework Programme (FP7/2007-2013), Grant Agreement no. 260576.

  • Aggressotype (Aggression subtyping for improved insight and treatment innovation in psychiatric disorders)
    European Union’s Seventh Framework Programme for research, technological development and demonstration, Grant Agreement no. 602805.

  • MATRICS (Multidisciplinary Approaches to Translational Research In Conduct Syndromes)
    European Union’s Seventh Framework Programme for research, technological development and demonstration, Grant Agreement no. 603016. 

ECAPN (European Child & Adolescent Psychopharmacology Network)
ECAPN is an initiative of the ECNP Child & Adolescent Neuropsychopharmacology Network.
Read more here and check the output page.

ECAPN in Enpr-EMA
The European Child & Adolescent Psychopharmacology Network (ECAPN) has been recognized as an Enpr-EMA Network.

Neuroscience-based Nomenclature Initiative

  • The Network worked on the Paediatric information of the NbN Initiative.

Recommended Publications

Authors   Year
  Title
 Journal and link to article
Moreno and Zuddas
  2019   Re-thinking treatment targets in child and adolescent psychiatry European Child & Adolescent Psychiatry
Persico et al.
 2015  Unmet needs in paediatric psychopharmacology: present scenario and future perspectives  European Neuropsychopharmacology


Other applications (unsuccessful in being funded or not yet funded)

  • APPLE (Antipsychotics in the paediatric population: limiting exposure)
  • OPTI-MED (Establishing optimal ADHD medication strategies across Europe)
  • TAPS (Treatment of ADHD in Pre-Schoolers)
  • NIOTAS (Neuroimmune Interactions in Obsessive-Compulsive, Tourette’s, ADHD and Autism Spectrum Disorders)
  • METPSY (Understanding co-morbidity between cardio-metabolic disorders and severe psychiatric disorders through trans-generational, and early life course approach)
  • COBRA (COmputational approaches for Biomarker Identification in ADHD)

Targeted Network Meetings